Answers are grounded in this paper and cite their sources.
The article discusses particular circumstances of acute coronary syndrome (ACS) in patients with type 2 diabetes (T2D). In addition, the available literature data and clinical guidelines reflecting the role of hypoglycemic therapy as a cardioprotection factor in ACS are analyzed. The article considers possible protective molecular mechanisms of various groups of drugs in ischemic cardiomyocytes.
No takes yet. Share an insight, caveat, or question.
Nikolaev et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: